Capital Fund Management (CFM)’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.6M Buy
203,628
+27,987
+16% +$3.52M 0.07% 81
2025
Q1
$19.4M Buy
175,641
+71,117
+68% +$7.87M 0.06% 107
2024
Q4
$14.3M Sell
104,524
-7,048
-6% -$962K 0.04% 202
2024
Q3
$12.9M Buy
111,572
+54,621
+96% +$6.29M 0.04% 188
2024
Q2
$7.84M Buy
+56,951
New +$7.84M 0.02% 245
2021
Q2
Sell
-60,266
Closed -$5.86M 782
2021
Q1
$5.86M Buy
60,266
+40,409
+204% +$3.93M 0.06% 141
2020
Q4
$1.9M Sell
19,857
-2,810
-12% -$269K 0.02% 296
2020
Q3
$2.18M Buy
22,667
+3,329
+17% +$320K 0.03% 258
2020
Q2
$2.36M Sell
19,338
-4,305
-18% -$525K 0.04% 178
2020
Q1
$2.05M Buy
+23,643
New +$2.05M 0.03% 262
2019
Q4
Hold
0
1056
2019
Q3
Sell
-6,932
Closed -$585K 947
2019
Q2
$585K Buy
6,932
+3,612
+109% +$305K 0.01% 505
2019
Q1
$292K Sell
3,320
-21,712
-87% -$1.91M ﹤0.01% 671
2018
Q4
$1.79M Buy
25,032
+13,732
+122% +$981K 0.02% 391
2018
Q3
$1.39M Buy
+11,300
New +$1.39M 0.01% 530
2018
Q2
Hold
0
1137
2018
Q1
Hold
0
1092
2017
Q2
Sell
-146,598
Closed -$6.35M 971
2017
Q1
$6.35M Buy
146,598
+117,886
+411% +$5.1M 0.05% 222
2016
Q4
$1.11M Buy
28,712
+15,760
+122% +$610K 0.01% 534
2016
Q3
$656K Sell
12,952
-64,169
-83% -$3.25M 0.01% 602
2016
Q2
$3.51M Buy
77,121
+68,711
+817% +$3.12M 0.03% 305
2016
Q1
$333K Sell
8,410
-84,126
-91% -$3.33M ﹤0.01% 720
2015
Q4
$5.24M Sell
92,536
-217,173
-70% -$12.3M 0.05% 236
2015
Q3
$12.3M Buy
309,709
+238,342
+334% +$9.48M 0.14% 104
2015
Q2
$3.41M Buy
+71,367
New +$3.41M 0.04% 236